|Wiley Systems, Inc. Announces Two New Wiley Protocol Rhythms at ACAM: Snooz and Sparc Therapy|
Wiley Systems, Inc. Announces Two New Wiley Protocol Rhythms at ACAM: Snooz and Sparc Therapy
Santa Barbara, CA, (MarketWire) November 3, 2009–Wiley Systems™, Inc., developer of the Wiley Protocol biomimetic rhythmic hormones, announces two new Wiley Protocol rhythms at the American College for Advancement in Medicine (ACAM) at Booth 518, November 4-8, 2009 at the Rio Las Vegas hotel, Las Vegas, Nevada. The rhythmic protocols include Snooz™ - Seasonal Neuroendocrine Optimal Organizational Zeitgeber; Melatonin, and Sparc™ Therapy - Seasonal Pulsatile Adrenal Recalibration; Cortisol capsules. These protocols will be available doctors and pharmacists by December 1, 2009.
Melatonin is a naturally occurring hormone that regulates the circadian rhythms of several biological functions. Cortisol is produced by the pituitary gland makes adrenocorticotropic hormone, or ACTH, which stimulates the adrenal gland, producing Cortisol. If a person doesn’t have enough ACTH to stimulate the adrenal gland to make Cortisol, or if the adrenal gland is not able to make Cortisol, this person will need to take Cortisol replacement therapy.
“The rhythm of nature is so internalized that every molecular action of every hormone to its receptor, on every gene in every cell, functioning in every organ of your body, hears the cosmic tune,” said T.S. Wiley, author and developer of the Wiley Protcol. “Cortisol, insulin melatonin, prolactin, progesterone, estrogen, testosterone, and growth hormone all play like the keys of a grand piano in response to environmental sheet music.
T.S. Wiley is the developer of The Wiley Protocol® rhythmic, compounded bioidentical hormones, and has pioneered the standardization of the patent protected Wiley Protocol formulations using unique, standardized compounding procedures and color coded packaging, available to physicians and patients at recommended retail prices. The company’s biomimetic hormone protocols must be formulated by a trained and registered compounding pharmacist.
Wiley Systems, Inc distributes the following biomimetic dosing schedules: The Wiley Protocol™ for Women; Wiley Protocol for Men™, biomimetic DHEA and testosterone restoration; Wiley Protocol Thyroid™ for Women, biomimetic thyroid hormone restoration; Wiley Protocol Testosterone™ for Women, biomimetic testosterone restoration; and Wiley Protocol Face Crème™, which promotes a more youthful appearance by filling in fine lines with the body’s own adiposities.
To learn more online, visit www.thewileyprotocol.com or go to the Bioidenticals Channel on YouTube where you may watch and listen to patients and doctors talk about their experiences with the rhythmic Wiley Protocol.
T.S. Wiley is a medical theorist in environmental endocrinology and Darwinian medicine. She is a noted writer, researcher and lecturer on the effects of hormones, particularly in menopausal women as well as an accepted expert in chronobiology and circadian rhythmicity. Wiley’s environmental endocrinology seminars, “Two Days Back on Earth” in Los Angeles, California are attended by physicians from around the world.
About the American College for Advancement in Medicine (ACAM)
ACAM is a not-for-profit association dedicated to educating physicians and other health care professionals on the latest findings and emerging procedures in complementary, alternative and integrative (CAIM) medicine. ACAM is the voice of integrative medicine; our goals are to improve physician skills, knowledge and diagnostic procedures as they relate to complementary and alternative medicine; to support integrative medicine research; and to develop awareness of alternative methods of medical treatment. ACAM enables members of the public to connect with physicians who take an integrative approach to patient care and empowers people with information about integrative medicine treatment options.
About Wiley Systems, Inc. and the Wiley Protocol
Wiley Systems, Inc. was founded in 2005 in Santa Barbara, California by T.S. Wiley, who is the developer of the Wiley Protocol®, a trademarked patent protected delivery system consisting of the biomimetic, bioidentical hormones estradiol and progesterone, or biomimetic hormone restoration therapy. Wiley Systems began as a project to fund the union of doctors and pharmacists in a common goal to standardize bioidentical hormones for academic research. Now in 2009, the Wiley Pharmacy Consortium numbers around 50 pharmacies and more than 250 doctors prescribing in the US and Canada.
The Wiley Protocol is only available at compounding pharmacies that have joined the project for future National Institutes of Health (NIH) study and have contractually agreed to the standardized methods, materials, packaging and recommended pricing. In exchange, Wiley Systems provides intellectual property and provides 28WP logo-bearing packaging consisting of color-coded bags and applicators. The Wiley Protocol name assures customers that they are receiving authentic Wiley Protocol dosing rhythms based on original research.
Wiley Systems, Inc.